The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation
- Nat Commun. 2021 May 11;12(1):2713. doi: 10.1038/s41467-021-22979-3.
- 1. The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
- 2. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.
- 3. Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
- 4. Department of Microbiology, Monash University, Clayton, VIC, Australia.
- 5. Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia.
- 6. The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. [email protected].
- 7. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. [email protected].
- 8. Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia. [email protected].
- 9. Department of Molecular and Translational Science, Monash University, Clayton, VIC, Australia. [email protected].
- 10. The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. [email protected].
- 11. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia. [email protected].
- # Contributed equally.
Interleukin-1β (IL-1β) is activated by inflammasome-associated Caspase-1 in rare autoinflammatory conditions and in a variety of Other inflammatory diseases. Therefore, IL-1β activity must be fine-tuned to enable anti-microbial responses whilst limiting collateral damage. Here, we show that precursor IL-1β is rapidly turned over by the Proteasome and this correlates with its decoration by K11-linked, K63-linked and K48-linked ubiquitin chains. The ubiquitylation of IL-1β is not just a degradation signal triggered by inflammasome priming and activating stimuli, but also limits IL-1β cleavage by Caspase-1. IL-1β K133 is modified by ubiquitin and forms a salt bridge with IL-1β D129. Loss of IL-1β K133 ubiquitylation, or disruption of the K133:D129 electrostatic interaction, stabilizes IL-1β. Accordingly, Il1bK133R/K133R mice have increased levels of precursor IL-1β upon inflammasome priming and increased production of bioactive IL-1β, both in vitro and in response to LPS injection. These findings identify mechanisms that can limit IL-1β activity and safeguard against damaging inflammation.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Proteasome; NF-κB; Apoptosis; Autophagy; TREM receptor; Ligands for Target Protein for PROTACResearch Areas: Cancer